Industry News
Palatin Releases Updated Responder Analysis Results from Phase 3 Melody-1 Trial in Dry Eye Disease

Palatin Technologies has announced updated results from responder analyses of its pivotal Phase 3 Me...

read more
Palatin Releases Updated Responder Analysis Results from Phase 3 Melody-1 Trial in Dry Eye Disease
April 30, 2025
Ace Vision Group Closes $29.4 Million Series B Financing to Advance Presbyopia Laser Technology

Ace Vision Group (AVG) has announced the successful closing of a $29.4 million Series B financing ro...

read more
Ace Vision Group Closes $29.4 Million Series B Financing to Advance Presbyopia Laser Technology
April 30, 2025
UNITY Biotechnology Announces NEJM Evidence Publication of Phase 2 UBX1325 Data in DME

UNITY Biotechnology has announced that NEJM Evidence has published results from the Phase 2 BEHOLD s...

read more
UNITY Biotechnology Announces NEJM Evidence Publication of Phase 2 UBX1325 Data in DME
April 29, 2025
iStar Medical Announces Positive 5-Year Results of MINIject in Glaucoma Patients

iStar Medical has announced positive 5-year results from the STAR-GLOBAL trial evaluating the long-t...

read more
iStar Medical Announces Positive 5-Year Results of MINIject in Glaucoma Patients
April 28, 2025
Bausch + Lomb Resolves enVista IOL Recall Issue and Begins Product Relaunch

Bausch + Lomb has identified the root cause of a recent voluntary recall of select intraocular lense...

read more
Bausch + Lomb Resolves enVista IOL Recall Issue and Begins Product Relaunch
April 28, 2025
Positive Topline Results from Phase 2 VVN461 Trial for Non-Infectious Anterior Uveitis

VivaVision Biotech has announced positive topline results from its Phase 2 clinical trial of VVN461,...

read more
Positive Topline Results from Phase 2 VVN461 Trial for Non-Infectious Anterior Uveitis
April 28, 2025
India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children

Entod Pharmaceuticals has received marketing authorization from the Central Drugs Standard Control O...

read more
India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children
April 24, 2025
Zhaoke Ophthalmology Enrolls First Patient in Phase 3 Trial of Cyclosporine Ophthalmic Gel for Dry Eye Disease

Zhaoke Ophthalmology has announced the enrollment of the first patient in its Phase 3 clinical trial...

read more
Zhaoke Ophthalmology Enrolls First Patient in Phase 3 Trial of Cyclosporine Ophthalmic Gel for Dry Eye Disease
April 21, 2025
MST Forms Strategic Distribution Partnership with Mani to Expand Ophthalmic Surgical Blade Access in the U.S.

Microsurgical Technology (MST) has announced a strategic partnership with Japanese manufacturer Mani...

read more
MST Forms Strategic Distribution Partnership with Mani to Expand Ophthalmic Surgical Blade Access in the U.S.
April 18, 2025
FDA Accepts Regeneron’s sBLA for EYLEA HD for Priority Review

The U.S. Food and Drug Administration (FDA) has accepted Regeneron’s supplemental Biologics License ...

read more
FDA Accepts Regeneron’s sBLA for EYLEA HD for Priority Review
April 18, 2025
More